Drug & intervention

Zirabev

RxCUI 2268040

Clinical trials2

Recruiting0

Related conditions9

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

2 shown

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerNCT04889495 · 2025-05-16

Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small Cell Lung Cancer With Progression on Previous Third-generation EGFR-TKINCT05601973 · 2023-03-27

ACTIVE_NOT_RECRUITING

Conditions being studied

Cervical Cancer1 Epithelial Ovarian Cancer1 Fallopian Tube Cancer1 Metastatic Breast Cancer1 Metastatic Colorectal Cancer1 Metastatic Kidney Cancer1 Non Small Cell Lung Cancer1 Non-small Cell Lung Cancer1 Primary Peritoneal Cancer1

Research locations

A CoruñaSpain1 AlicanteSpain1 AmsterdamNetherlands1 AngersFrance1 BarcelonaSpain1 BernSwitzerland1 GenevaSwitzerland1 LondonUnited Kingdom1 LyonFrance1 MadridSpain1

Leading sponsors

ETOP IBCSG Partners Foundation1 Pfizer1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.